^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
AmoyDx® KRAS Mutation Detection Kit

Type:
CE Marked
Related tests:
Evidence

News

1year
Prevalence of KRAS p.G12C mutation in patients with metastatic non-small cell lung cancer in Argentina. (ASCO 2023)
This study represents a deep understanding of KRAS p.G12C mutational landscape in the Argentine population and its association with demographic and clinical characteristics and demonstrates that qPCR is a feasible methodology for routine testing.
Clinical • Metastases
|
KRAS (KRAS proto-oncogene GTPase) • KIT (KIT proto-oncogene, receptor tyrosine kinase)
|
KRAS mutation • KRAS G12C • KRAS G12
|
AmoyDx® KRAS Mutation Detection Kit